Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome.

BACKGROUND: Serum baseline tryptase (sBT) is a minor diagnostic criterion for systemic mastocytosis (SM) of undetermined prognostic impact. We monitored sBT levels in indolent SM (ISM) patients and investigated its utility for predicting disease behaviour and outcome. METHODS: In total 74 adult ISM...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Almudena Matito, José Mario Morgado, Iván Álvarez-Twose, Laura Sánchez-Muñoz, Carlos Eduardo Pedreira, María Jara-Acevedo, Cristina Teodosio, Paula Sánchez-López, Elisa Fernández-Núñez, Ricardo Moreno-Borque, Andrés García-Montero, Alberto Orfao, Luis Escribano
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2013-01-01
coleção:	PLoS ONE
Acesso em linha:	http://europepmc.org/articles/PMC3796517?pdf=render
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!